Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

AMPAC Fine Chemicals to Manufacture Smallpox Countermeasure API

By Pharmaceutical Processing | August 12, 2011

 

AMPAC Fine Chemicals LLC (AFC), a wholly-owned subsidiary of
American Pacific Corporation, has concluded an agreement with Chimerix, Inc. to
validate at commercial scale the manufacturing process for the API in
Chimerix’s broad spectrum antiviral drug candidate, CMX001, which is being
developed for the prevention and treatment of smallpox. Chimerix will provide
the investigational drug product under a Prime Contract with the U.S.
Government Agency BARDA (Biomedical Advanced Research and Development
Authority). According to Kenneth I. Moch, President and Chief Executive Officer
of Chimerix, “We look forward to working with AFC and BARDA to harness the
full potential of CMX001 to address the biodefense threat represented by
smallpox.”

The validation campaign will be conducted in AFC’s recently
completed second semi-works unit. The unit is located within a secured
perimeter (security-alarmed fencing, cameras, controlled personnel access)
segment of AFC on the DoD-regulated campus of Aerojet/GenCorp in Rancho Cordova. “This facility offers a state of the
art, remotely operated process plant which can safely run hydrogenations and
hazardous chemical processes, while containing reactants and products with
Occupational Exposure Limits (OELs) down to 0.5 µg/m3, combining two of the
core strengths of AFC. Equipment consists of 4 reactors (from 300-750 gal) and
one 2.0 m2 Hastelloy filter-dryer. The unit is ideally suited for the
production of APIs required by companies like Chimerix,” stated Larry
Zeagler, Executive Director of Product Management for AFC.

“This agreement further solidifies our position as a
supplier with world class cGMP manufacturing capabilities in the United States.
AFC is committed to maintaining the domestic assets and services needed by our
customers to provide materials of critical importance to health and
safety,” stated Aslam Malik, President of AFC.

 

Related Articles Read More >

Astellas
Astellas to spend $70M on new biotech campus in South San Francisco
Rainin
Mettler Toledo Rainin expands facilities in Vacaville, California
Elemental Machines
Elemental Machines aims to enlist lab freezers in fight against climate change 
Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards